{
    "Trade/Device Name(s)": [
        "MAGLUMI 2000 25-OH Vitamin D"
    ],
    "Submitter Information": "Shenzhen New Industries Biomedical Engineering Co., Ltd.",
    "510(k) Number": "K191499",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112725"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "August 1, 2019",
    "Summary Letter Received Date": "June 6, 2019",
    "Submission Date": "July 26, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "25-OH Vitamin D",
        "25-OH Vitamin D2",
        "25-OH Vitamin D3",
        "Vitamin D2",
        "Vitamin D3",
        "1,25-(OH)2-Vitamin D3",
        "1,25-(OH)2-Vitamin D2",
        "3-epi-25OH D3"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Plain serum tube",
        "Serum separator tube"
    ],
    "Instrument(s)/Platform(s)": [
        "MAGLUMI 2000 Fully-auto chemiluminescence immunoassay analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Competitive immunoassay",
        "Two-step incubation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for MAGLUMI 2000 25-OH Vitamin D chemiluminescence immunoassay for quantification of 25-OH Vitamin D in human serum",
    "Indications for Use Summary": "In vitro chemiluminescence immunoassay for the quantitative determination of 25-OH Vitamin D in human serum using MAGLUMI 2000 analyzer, as an aid in assessing vitamin D sufficiency",
    "fda_folder": "Clinical Chemistry"
}